Daniel Wolf and Jonathan Davis are profiled as a winning M&A team. The article discusses the duo's successful representation of Bristol-Myers Squibb in its $74 billion acquisition of Celgene Corp.—the largest-ever acquisition of a pharmaceutical company.
“'This deal had it all,” Davis says. 'It was a very large transaction, and it was also complex from the antitrust approval perspective.'”
Read the full article